Current position

Joel Greenblatt’s Veracyte Inc (VCYT) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Gotham Asset ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2019Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares72.48KHighest verified quarter-end share count
Quarters reported21Verified quarters with shares above zero
What happened?

Gotham Asset Management first reported Veracyte Inc in Q2 2019. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Gotham Asset Management currently reports 23.34K shares. The latest verified filing showed: Sold 67.8% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 67.8% of the position−49.14K shares · 23.34K shares remained
Filing context

Quarter-end price $58.73

Q1 2026
Bought 4.2% more+2.90K shares · 72.48K shares reported after the change
Filing context

Quarter-end price $32.21

Q4 2025
Bought 210.3% more+47.15K shares · 69.57K shares reported after the change
Filing context

Quarter-end price $42.10

Q3 2025
Sold 31.9% of the position−10.52K shares · 22.42K shares remained
Filing context

Quarter-end price $34.33

Q2 2025
Bought 74.5% more+14.06K shares · 32.94K shares reported after the change
Filing context

Quarter-end price $27.03

Q1 2025
Sold 5.9% of the position−1.18K shares · 18.88K shares remained
Filing context

Quarter-end price $29.65

Portfolio importance

How important is Veracyte Inc in Gotham Asset Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#1267of 1791 reported positions
Peak portfolio weight0.1%Q3 2021
Best historical rank#391Q3 2021
At peak importanceQ3 2021
VCYT
0.1%
Largest holding
2.6%
Cross-investor discovery

Who else owns Veracyte Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Cathie WoodARK Investment Management
VCYT0.9% of reported portfolio
Ray DalioBridgewater Associates, LP
VCYT0.0% of reported portfolio
Explore Veracyte Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$40.142026-09-15

Market context only; not an investor transaction price.

Latest filing quarter-end price$58.73Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Gotham Asset Management, LLC’s Form 13F disclosures—not Joel Greenblatt’s personal brokerage account. The filing is firm-level rather than a personal stock list. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.